AGREEMENT BETWEEN NAVIDEA BIOPHARMACEUTICALS, INC. AND ALSERES PHARMACEUTICALS, INC.Confidential Treatment • April 27th, 2015 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Delaware
This Agreement (“Agreement”) is made and entered into effective April 21, 2015 (the “Effective Date”) by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation having an address at 5600 Blazer Parkway, Suite 200, Dublin, OH 43017-1367 (“NAVB”) and Alseres Pharmaceuticals, Inc., a Delaware corporation having an address at 10 Rogers Street, Suite 101, Cambridge, MA 02142 (“ALSE”). Each of NAVB and ALSE may be referred to herein as a “Party” and collectively as the “Parties”.
